Skip to main content

Accelerate Diagnostics Files $150M Shelf Registration

NEW YORK (GenomeWeb News) – Accelerate Diagnostics has filed a shelf registration to publicly offer from time to time up to $150 million of securities.

In a Form S-3 filed with the US Securities and Exchange Commission on Wednesday, the company said that it may offer common stock, preferred stock, debt securities, warrants, and/or units in combination. Net proceeds from any offering will go toward general corporate purposes.

During the summer, Accelerate said that it raised $20 million in a rights offering. Last week, it disclosed in an SEC filing a year over year increase in its third quarter revenues.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.